|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Rilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label, dose de-escalation phase 1b study and a double-blind, randomised phase 2 study显示文摘 | Timothy Iveson Ross C Donehower Irina Davidenko Sergey Tjulandin Andrzej Deptala Mark Harrison Somanath Nirni Kuntegowdanahalli Lakshmaiah Anne Thomas Yizhou Jiang Min Zhu Rui Tang Abraham Anderson Sarita Dubey Kelly S Oliner Elwyn Loh | 2014 | Lancet Oncology2014，，9： | 3 |
| 2 | Geologic evolution of the himalayan-Tibetan orogen 显示文摘 | YIN An Harrison T Mark | 2000 | Annual Review of Earth and Planetary Sci- ences2000，28，： | 1 |
| 3 | Stimulation of auto-logous proliferative and cytotoxic T-cell responses by 'leukemia dendritic cells' derived from blast cells in acute myeloid leukemia显示文摘 | Harrison BD Adams JA Mark B | 2001 | Blood2001，97，9： | 1 |
| 4 | Wave effects in isolation mounts 显示文摘 | Mark Harrison Alan O Sykes M Martin | 1952 | J Acoust Soc Amer1952，，24： | 1 |
| 5 | Stable carbon isotope ratio analysis of Australian orange juices显示文摘 | Wayne A Simpkins Gordhan Patel Mark Harrison David Goldberg | 2000 | Food Chemistry2000，，3： | 1 |
| 6 | Adding sense to the Internet of Things显示文摘 | Tomás Sánchez López Damith C. Ranasinghe Mark Harrison Duncan McFarlane | 2012 | Personal and Ubiquitous Computing2012，，3： | 1 |
| 7 | Hyperbaric oxygen for patients with chronic bowel dysfunction after pelvic radiotherapy (HOT2): a randomised, double-blind, sham-controlled phase 3 trial显示文摘 | Mark Glover Gary R Smerdon H Jervoise Andreyev Barbara E Benton Pieter Bothma Oliver Firth Lone Gothard John Harrison Mihaela Ignatescu Gerard Laden Sue Martin Lauren Maynard Des McCann Christine E L Penny Spencer Phillips Grace Sharp John Yarnold | 2016 | The Lancet Oncology2016，，2： | 1 |
| 8 | Abnormal white matter microstructure in schizophrenia: A voxelwise analysis of axial and radial diffusivity显示文摘 | Marc L. Seal Murat Yücel Alex Fornito Stephen J. Wood Ben J. Harrison Mark Walterfang Gaby S. Pell Christos Pantelis | 2008 | Schizophrenia Research2008，，1： | 1 |
| 9 | Characterization of particles from a current technology heavy-duty diesel engine 显示文摘 | Shi J P Mark D Harrison R M | 2000 | Environmental Science & Technology2000，34，5： | 1 |
| 10 | Cretaceous-Tertiary shortening, basin development, and volcanism in central Tibet 显示文摘 | Kapp Paul Yin An Harrison T Mark | 2005 | GSA Bulletin2005，117，78： | 1 |
| 11 | Transgenic swine: Expression of human CD39 protects against myocardial injury显示文摘 | Debra G. Wheeler Matthew E. Joseph Shouvik D. Mahamud William L. Aurand Peter J. Mohler Vincent J. Pompili Karen M. Dwyer Mark B. Nottle Sharon J. Harrison Anthony J.F. d’Apice Simon C. Robson Peter J. Cowan Richard J. Gumina | 2012 | Journal of Molecular and Cellular Cardiology2012，，5： | 1 |
| 12 | Diffusion of 40Ar in hornblende显示文摘 | T. Mark Harrison | 1982 | Contributions to Mineralogy and Petrology1982，，3： | 1 |
| 13 | Diffusion of ^40Ar in hornblende 显示文摘 | Mark Harrison T | 1981 | Conuibutions to Mineralogy and Petrology1981，78，3： | 1 |
| 14 | 糖尿病视网膜病变和黄斑囊样水肿患者曲安奈德眼内注射前、后玻璃体内血管内皮生长因子和基质衍生因子-1的水平显示文摘背景:能导致糖尿病视网膜病变(DR)视力丧失的弥漫性黄斑囊样水肿(DME)和(或)异常新生血管(NV)可能受生长因子和化学激活剂的调节。化学激活素基质衍生因子-1(SDF-1)是一种血管内皮生长因子(VEGF)表达的有效刺激剂,是NV的重要效应物。并且是与发生DME有关血管通透性的关键诱导物。循环中的内皮前体细胞对SDF-1应答迁徙参与NV。目的:调查不同程度的的DR和DME患者。在眼内注射曲安奈德(triamcinolone acetonide)前后,玻璃体中SDF-1和VEGF之间的关系。用于治疗难治的DME。方法:在这一前瞻性的研究中。包括36例患者并观察了6个月。在紧接着注射曲安奈德前和注射1个月后获得的标本,用酶联免疫吸附试验检测玻璃体中VEGF和SDF-1的水平。结果:增生性DR患者的VEGF和SDF-1与非增生DR患者相比显著高(P〈0.01)。DME患者与非DME患者相比较。SDF-1水平显著增加。VEGF与SDF-1的水平和疾病的严重程度相关(r^2=0.88)。结论:应用曲安奈德出现了激动人心的结果,VEGF和SDF-1降到了几乎检测不出来的水平。消除了DME并使活动性的NV退化。我们的结果支持SDF-1和VEGF在DR有害视力后果的发病机制中的作用,并提示注射曲安奈德后,可能由于抑制了VEGF和SDF-1,使得DME消退和(或)NV开始纤维化的退化。 | H. Logan Brooks Sergio Caballero Charles K. Newell Robert L. Steinmetz Debbie Watson Mark S. Segal Jeffrey K. Harrison Edward W. Scott Maria B. Grant 孙文赏(译) 申敏如(校) | 2005 | 美国医学会眼科杂志(中文版)2005，17，2： | 1 |
| 15 | Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial显示文摘 | Susan J Dutton David R Ferry Jane M Blazeby Haider Abbas Asa Dahle-Smith Wasat Mansoor Joyce Thompson Mark Harrison Anirban Chatterjee Stephen Falk Angel Garcia-Alonso David W Fyfe Richard A Hubner Tina Gamble Lynnda Peachey Mina Davoudianfar Sarah R Pear | 2014 | Lancet Oncology2014，，8： | 1 |
| 16 | 科艺共舞,神与物游——旅游规划中的科学与艺术显示文摘作为一种旅游价值实现与道德实践过程,旅游规划本身就是一个多元复杂的系统工程,是一个不断修正、完善、提升的动态过程。科学求真与艺术求美在这一历程中的关系时分时合,错综复杂,展现了科学与艺术的精彩浪漫之旅。 | Mark Harrison 金世胜 | 2013 | 旅游学刊2013，28，10： | 1 |
| 17 | Tertiary structural evolution of the Gangdese thrustsystem, southeastern Tibet 显示文摘 | Yin An Harrison T Mark Ryerson F J | 1994 | Journal of Geophysical Research1994，99，18： | 1 |
| 18 | Argon diffusion domains in K-feldspar II: kinetic properties of MH-10显示文摘 | Oscar M. Lovera Matthew T. Heizler T. Mark Harrison | 1993 | Contributions to Mineralogy and Petrology1993，，3： | 1 |
| 19 | Characterization of particles from a current technology heavy-duty diesel engine 显示文摘 | SHI J P MARK D HARRISON R M | 2000 | Environmental Science & Technology2000，34，5： | 1 |
| 20 | Domestic UK retrofit challenge : Barriers, incentives and current performance leading into the Green Deal 显示文摘 | Mark Dowson Adam Poole David Harrison Gideon Susman | 2012 | Energy Policy2012，50，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员